Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients.


Department of Pharmacy, Samuel S. Stratton Veterans Affairs Medical Center, Albany, NY, USA; Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA. Electronic address: [Email]


Four regimens are recommended for treating hepatitis C (HCV) genotype 1 infection. Study aims were to (1) compare frequencies of contraindicated drug interactions (XDDIs) when each HCV regimen is added to medication profiles of HCV-monoinfected patients, (2) quantify the proportion of patients with XDDIs to all four regimens and (3) determine covariates independently associated with having a XDDI to all four regimens.



OUR Recent Articles